williams-recalibratingthe-2017.pdf (378.22 kB)
Recalibrating the risks and benefits of lithium therapy
journal contributionposted on 2017-07-01, 00:00 authored by Michael BerkMichael Berk, Stephanie Cowdery, Lana WilliamsLana Williams, G S Malhi
Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.